BAFL 48.16 Increased By ▲ 1.66 (3.57%)
BIPL 21.65 Increased By ▲ 0.50 (2.36%)
BOP 5.64 Increased By ▲ 0.11 (1.99%)
CNERGY 5.12 Increased By ▲ 0.22 (4.49%)
DFML 19.40 Increased By ▲ 0.58 (3.08%)
DGKC 81.35 Increased By ▲ 1.35 (1.69%)
FABL 32.00 Increased By ▲ 1.15 (3.73%)
FCCL 20.40 Increased By ▲ 0.01 (0.05%)
FFL 9.80 Increased By ▲ 0.24 (2.51%)
GGL 13.88 Decreased By ▼ -0.09 (-0.64%)
HBL 120.54 Increased By ▲ 2.59 (2.2%)
HUBC 122.50 Decreased By ▼ -1.30 (-1.05%)
HUMNL 8.13 Increased By ▲ 0.18 (2.26%)
KEL 3.83 Increased By ▲ 0.32 (9.12%)
LOTCHEM 28.55 No Change ▼ 0.00 (0%)
MLCF 42.50 Increased By ▲ 0.40 (0.95%)
OGDC 122.37 Increased By ▲ 1.36 (1.12%)
PAEL 19.85 Increased By ▲ 1.01 (5.36%)
PIBTL 5.80 Increased By ▲ 0.10 (1.75%)
PIOC 117.16 Increased By ▲ 3.45 (3.03%)
PPL 110.40 Increased By ▲ 2.05 (1.89%)
PRL 29.58 Increased By ▲ 1.76 (6.33%)
SILK 1.10 Increased By ▲ 0.03 (2.8%)
SNGP 69.90 Increased By ▲ 0.50 (0.72%)
SSGC 13.85 Increased By ▲ 0.60 (4.53%)
TELE 9.11 Increased By ▲ 0.32 (3.64%)
TPLP 14.40 Increased By ▲ 0.75 (5.49%)
TRG 94.75 Increased By ▲ 2.81 (3.06%)
UNITY 27.40 Increased By ▲ 0.74 (2.78%)
WTL 1.62 Increased By ▲ 0.05 (3.18%)
BR100 6,642 Increased By 98 (1.5%)
BR30 23,606 Increased By 395.5 (1.7%)
KSE100 64,605 Increased By 687.5 (1.08%)
KSE30 21,541 Increased By 189.4 (0.89%)

WASHINGTON: Pharmaceutical giant AstraZeneca said Monday that trials showed its Covid-19 vaccine was 100 percent effective in preventing severe disease, as a row simmered between Britain and the EU over much-needed supplies of the jab. The AstraZeneca shot is cheaper and easier to store than many of its rivals, several countries in Europe and other parts of the world last week suspended its use because of isolated cases of blood clots.

It is also at the centre of a row between Britain and the EU, after Brussels threatened to ban exports to the UK unless the company delivers more of the 90 million doses it agreed to supply in the first quarter of 2021. Irish prime minister Micheal Martin said such a move would be “a very retrograde step,” while Britain’s leader urged the European Union not to carry out its threat. “We’re all facing the same pandemic, we all have the same problems,” Prime Minister Boris Johnson said on Monday.

“Developing vaccines, rolling them out, these are international projects and they require international cooperation.” The spat is mostly focused on a Netherlands factory that is still awaiting official EU approval, but which both sides claim as a future source of the AstraZeneca jab.

Vaccination drives are seen as crucial to overcoming the pandemic that has killed more than 2.7 million people since first emerging in China in late 2019. They are also the most likely route out of lockdowns and restrictions that continue to paralyze economies around the world. More than 430 million jabs have now been rolled out globally, mostly in wealthier nations while many poor countries have yet to receive a single dose.

A survey by British pollsters YouGov showed Monday that a majority of people in the biggest EU states — including Germany, France, Spain and Italy — view the vaccine as unsafe.

And on Monday, Iceland said it would not yet be resuming AstraZeneca vaccinations after halting them earlier this month. The EU’s medicines regulator and the WHO insist there is no evidence of linking the drug to blood clots. And AstraZeneca said Monday that US tests on more than 30,000 people showed no increased risk of thrombosis.

It said the jab was 79 percent effective at preventing symptomatic Covid-19 in the overall population, 100 percent effective at preventing severe disease and hospitalization and 80 percent effective at preventing the disease in the elderly.

Putin hits back

A Russia-made vaccine, Sputnik V, has also met with skepticism in the West, because it was registered last year, before undergoing any large-scale clinical trials.

Some EU officials such as Internal Market Commissioner Thierry Breton continue snub the jab, saying on Sunday, “we have absolutely no need for Sputnik V”. But Russian President Vladimir Putin hit back against such comments on Monday.

European Medicines Agency were set to visit Russia next month to review clinical trials of Sputnik V. Other countries seem to have no such reservations.

The Russian Direct Investment Fund, which financially backed the vaccine, said it had signed an agreement with an India-based pharmaceuticals giant for the production of up to 200 million doses of the jab a year.

In the French Mediterranean port city of Marseille, roughly 6,500 people — mostly young and mostly without masks — took part in a carnival parade, flouting a ban on public gatherings.

Politicians themselves are not immune to people’s frustrations. On a visit to China, Russia’s Foreign Minister Sergei Lavrov sported some decidedly un-diplomatic facewear — a black mask with the inscription Church bells rang out across the Czech Republic Monday to mark one year since the first Covid-19 fatality in the nation, which has the highest per capita death rate in the world, according to data collected by AFP. And on Tuesday, Britain will mark the anniversary of the first coronavirus lockdown with a “National Day of Reflection”, which will see parliament hold a minute’s silence in tribute to the more than 125,000 people who have died.


Comments are closed.

AstraZeneca hails US trials as EU rows with UK over supplies

Intra-day update: rupee strengthens against US dollar

Intra-day update: KSE-100 crosses 64,900 after over 1,000-point gain

‘Illegal’ LCs, forex market speculation: MoF set to share list of banks with SIFC today

Illegal foreigners seriously affecting Pakistan’s security, economy: COAS

Israel advances in south Gaza city as fearful civilians search for safety

Soaring pollution in Pakistan’s Lahore fills wards with sick children

Oil rebounds from six-month-low but demand concerns linger

Loss-making Discos: FD opposes PD’s proposal

Power sector: Nepra backs transition from Libor to ‘SOFR’

FWBL sell-off: Minister briefed about status of accounts